Insiders · Profile

McNeely Theresa

EVP, Chief Comm. Officer at Tempest Therapeutics. Filing since 8 Apr 2015. CIK 0001627507

Company
Date
Role
Action
Shares
Amount
Of holding
9 Apr 2015
EVP, Chief Comm. Officer
Bought
226
$6.71K
130%
8 Apr 2015
EVP, Chief Comm. Officer
Bought
174
$5.01K
opened
2 decisions on file.